The overall objective of the Genetic Analysis of Idiopathic Thrombosis (GAIT) project is to identify genetic influences on susceptibility to thrombosis through genetic analyses of quantitative risk factors related to disease, including plasma levels of components of the hemostatic and fibrinolytic pathways as well as functional measures of protein activity and blood clotting efficiency. The GAIT sample includes 396 individuals in 21 multigenerational Spanish families for whom quantitative and diagnostic phenotypes are available as well as genotypes for a 10 cM genome scan. Analyses in the GAIT sample have previously documented the strong heritabiliites of many of these quantitative measures of hemostasis and fibrinolysis, identified which of these risk factors share pleiotropic genetic influences with liability to thrombosis, and localized quantitative trait loci (QTLs) influencing some of these traits. In the current grant period, we have followed up three of the most promising linkage results from the genome scan using standard fine-mapping techniques to narrow a linkage region on chromosome 10 for clotting factor XII levels and using a newly developed method, called Bayesian quantitative trait nucleotide (BQTN) analysis, to evaluate positional candidate genes within two regions of linkage, specifically the F12 gene under a linkage peak for factor XII levels and the TFPI gene under a linkage peak for tissue factor pathway inhibitor (TFPI) levels. In this renewal application, we propose to build on the results of these analyses through functional studies of variants identified in BQTN analyses, to extend our quantitative trait nucleotide studies to two new linkage signals with obvious positional candidate genes, and to replicate some of these findings in an independent data set.
The specific aims of the proposed research are:1) to follow-up three regions with strong linkage signals but no obvious candidate genes, including the factor XII linkage on chromosome 10, by assessing association with a gene-centric panel of SNPs;2) to determine whether CPB2 is the previously detected QTL on chromosome 13 influencing levels of thrombin-activatable fibrinolysis inhibitor (TAFI);3) to determine whether NNMT is the previously detected QTL on chromosome 11 influencing levels of homocysteine;and 4) to use in vitro functional studies to investigate potential mechanisms of action of polymorphisms identified as having a high posterior probability of effect in the quantitative trait nucleotide analyses.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Genomics, Computational Biology and Technology Study Section (GCAT)
Program Officer
Sarkar, Rita
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Texas Biomedical Research Institute
San Antonio
United States
Zip Code
Athanasiadis, Georgios; Buil, Alfonso; Souto, Juan Carlos et al. (2011) A genome-wide association study of the Protein C anticoagulant pathway. PLoS One 6:e29168
Almasy, Laura; Blangero, John (2010) Variance component methods for analysis of complex phenotypes. Cold Spring Harb Protoc 2010:pdb.top77
Calafell, Francesc; Almasy, Laura; Sabater-Lleal, Maria et al. (2010) Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels. Hum Mol Genet 19:517-25
Vila, Luis; Martinez-Perez, Angel; Camacho, Mercedes et al. (2010) Heritability of thromboxane A2 and prostaglandin E2 biosynthetic machinery in a Spanish population. Arterioscler Thromb Vasc Biol 30:128-34
Buil, Alfonso; Tregouet, David-Alexandre; Souto, Juan Carlos et al. (2010) C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood 115:4644-50
Sabater-Lleal, Maria; Chillón, Miguel; Mordillo, Carolina et al. (2010) Combined cis-regulator elements as important mechanism affecting FXII plasma levels. Thromb Res 125:e55-60
Almasy, Laura; Blangero, John (2009) Human QTL linkage mapping. Genetica 136:333-40
Viel, Kevin R; Ameri, Afshin; Abshire, Thomas C et al. (2009) Inhibitors of factor VIII in black patients with hemophilia. N Engl J Med 360:1618-27
Soria, José Manuel; Almasy, Laura; Souto, Juan Carlos et al. (2009) The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus. 2005. Hum Biol 81:853-67
Mälarstig, Anders; Buil, Alfonso; Souto, Juan Carolos et al. (2009) Identification of ZNF366 and PTPRD as novel determinants of plasma homocysteine in a family-based genome-wide association study. Blood 114:1417-22

Showing the most recent 10 out of 24 publications